Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (0874.HK)
HKD 16.62
(-0.36%)
HKD 16.62
(-0.36%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 14.18 Billion CNY | 6.85% |
| 2022 | 13.27 Billion CNY | 0.33% |
| 2021 | 13.23 Billion CNY | 26.75% |
| 2020 | 10.44 Billion CNY | -18.88% |
| 2019 | 12.87 Billion CNY | 27.82% |
| 2018 | 10.06 Billion CNY | 27.61% |
| 2017 | 7.89 Billion CNY | 19.13% |
| 2016 | 6.62 Billion CNY | -4.34% |
| 2015 | 6.92 Billion CNY | 4.5% |
| 2014 | 6.62 Billion CNY | 14.2% |
| 2013 | 5.8 Billion CNY | 155.13% |
| 2012 | 2.27 Billion CNY | 62.8% |
| 2011 | 1.39 Billion CNY | 9.11% |
| 2010 | 1.28 Billion CNY | 18.95% |
| 2009 | 1.07 Billion CNY | 0.62% |
| 2008 | 1.06 Billion CNY | -48.3% |
| 2007 | 2.06 Billion CNY | 16.98% |
| 2006 | 1.76 Billion CNY | 13.87% |
| 2005 | 1.55 Billion CNY | 11.25% |
| 2004 | 1.39 Billion CNY | -0.02% |
| 2003 | 1.39 Billion CNY | 6.33% |
| 2002 | 1.31 Billion CNY | 12.24% |
| 2001 | 1.17 Billion CNY | 14.55% |
| 2000 | 1.02 Billion CNY | 17.54% |
| 1999 | 869.1 Million CNY | 7.07% |
| 1998 | 811.73 Million CNY | 4.56% |
| 1997 | 776.34 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 2.65 Billion CNY | -2.29% |
| 2024 Q2 | 2.71 Billion CNY | -46.45% |
| 2024 Q1 | 5.07 Billion CNY | 101.8% |
| 2023 FY | 14.18 Billion CNY | 6.85% |
| 2023 Q2 | 3.28 Billion CNY | -34.67% |
| 2023 Q3 | 3.34 Billion CNY | 1.7% |
| 2023 Q1 | 5.03 Billion CNY | 106.41% |
| 2023 Q4 | 2.51 Billion CNY | -24.77% |
| 2022 Q4 | 2.43 Billion CNY | -22.13% |
| 2022 Q2 | 2.86 Billion CNY | -40.72% |
| 2022 Q1 | 4.83 Billion CNY | 101.64% |
| 2022 FY | 13.27 Billion CNY | 0.33% |
| 2022 Q3 | 3.13 Billion CNY | 9.25% |
| 2021 Q2 | 3.02 Billion CNY | -32.82% |
| 2021 Q1 | 4.5 Billion CNY | 240.04% |
| 2021 Q4 | 2.39 Billion CNY | -27.37% |
| 2021 Q3 | 3.3 Billion CNY | 9.16% |
| 2021 FY | 13.23 Billion CNY | 26.75% |
| 2020 FY | 10.44 Billion CNY | -18.88% |
| 2020 Q3 | 3.08 Billion CNY | 34.48% |
| 2020 Q4 | 1.32 Billion CNY | -57.11% |
| 2020 Q1 | 3.73 Billion CNY | 86.97% |
| 2020 Q2 | 2.29 Billion CNY | -38.44% |
| 2019 Q2 | 2.93 Billion CNY | -34.89% |
| 2019 FY | 12.87 Billion CNY | 27.82% |
| 2019 Q1 | 4.51 Billion CNY | 85.71% |
| 2019 Q3 | 3.42 Billion CNY | 16.74% |
| 2019 Q4 | 1.99 Billion CNY | -41.8% |
| 2018 Q2 | 2.12 Billion CNY | -20.19% |
| 2018 Q4 | 2.42 Billion CNY | -14.83% |
| 2018 FY | 10.06 Billion CNY | 27.61% |
| 2018 Q1 | 2.66 Billion CNY | 34.3% |
| 2018 Q3 | 2.85 Billion CNY | 34.13% |
| 2017 Q3 | 1.74 Billion CNY | -15.89% |
| 2017 FY | 7.89 Billion CNY | 19.13% |
| 2017 Q4 | 1.98 Billion CNY | 13.48% |
| 2017 Q2 | 2.07 Billion CNY | -0.19% |
| 2017 Q1 | 2.08 Billion CNY | 125.42% |
| 2016 FY | 6.62 Billion CNY | -4.34% |
| 2016 Q1 | 2 Billion CNY | 40.01% |
| 2016 Q2 | 2.12 Billion CNY | 6.01% |
| 2016 Q3 | 1.57 Billion CNY | -25.61% |
| 2016 Q4 | 923.58 Million CNY | -41.47% |
| 2015 Q2 | 2.19 Billion CNY | 31.46% |
| 2015 FY | 6.92 Billion CNY | 4.5% |
| 2015 Q1 | 1.66 Billion CNY | 15.57% |
| 2015 Q4 | 1.42 Billion CNY | -12.19% |
| 2015 Q3 | 1.62 Billion CNY | -25.87% |
| 2014 Q1 | 1.61 Billion CNY | 26.56% |
| 2014 Q3 | 1.61 Billion CNY | -17.11% |
| 2014 Q2 | 1.94 Billion CNY | 20.3% |
| 2014 FY | 6.62 Billion CNY | 14.2% |
| 2014 Q4 | 1.44 Billion CNY | -10.51% |
| 2013 FY | 5.8 Billion CNY | 155.13% |
| 2013 Q1 | 978.92 Million CNY | 16.26% |
| 2013 Q2 | 2.27 Billion CNY | 131.92% |
| 2013 Q4 | 1.27 Billion CNY | 0.45% |
| 2013 Q3 | 1.27 Billion CNY | -43.91% |
| 2012 Q3 | 601.81 Million CNY | 47.28% |
| 2012 Q1 | 421.64 Million CNY | 13.98% |
| 2012 FY | 2.27 Billion CNY | 62.8% |
| 2012 Q4 | 842.03 Million CNY | 39.91% |
| 2012 Q2 | 408.62 Million CNY | -3.09% |
| 2011 Q2 | 353.62 Million CNY | 2.31% |
| 2011 Q3 | 327.65 Million CNY | -7.34% |
| 2011 Q4 | 369.94 Million CNY | 12.9% |
| 2011 FY | 1.39 Billion CNY | 9.11% |
| 2011 Q1 | 345.63 Million CNY | 6.27% |
| 2010 Q1 | 313.32 Million CNY | -0.84% |
| 2010 Q3 | 305.58 Million CNY | -9.08% |
| 2010 FY | 1.28 Billion CNY | 18.95% |
| 2010 Q4 | 325.24 Million CNY | 6.43% |
| 2010 Q2 | 336.1 Million CNY | 7.27% |
| 2009 Q1 | 231.26 Million CNY | -16.01% |
| 2009 FY | 1.07 Billion CNY | 0.62% |
| 2009 Q4 | 315.97 Million CNY | 21.83% |
| 2009 Q3 | 259.36 Million CNY | -3.82% |
| 2009 Q2 | 269.65 Million CNY | 16.6% |
| 2008 FY | 1.06 Billion CNY | -48.3% |
| 2008 Q4 | 275.33 Million CNY | 57.36% |
| 2008 Q3 | 174.97 Million CNY | -59.63% |
| 2008 Q1 | 464.53 Million CNY | -30.14% |
| 2008 Q2 | 433.44 Million CNY | -6.69% |
| 2007 Q3 | 456.03 Million CNY | -6.66% |
| 2007 FY | 2.06 Billion CNY | 16.98% |
| 2007 Q1 | 459.43 Million CNY | 12.76% |
| 2007 Q2 | 488.59 Million CNY | 6.35% |
| 2007 Q4 | 664.97 Million CNY | 45.82% |
| 2006 Q1 | 452.62 Million CNY | 25.04% |
| 2006 Q4 | 407.43 Million CNY | -7.94% |
| 2006 FY | 1.76 Billion CNY | 13.87% |
| 2006 Q3 | 442.56 Million CNY | -5.06% |
| 2006 Q2 | 466.14 Million CNY | 2.99% |
| 2005 Q4 | 361.97 Million CNY | -3.82% |
| 2005 Q3 | 376.33 Million CNY | -7.97% |
| 2005 Q2 | 408.93 Million CNY | 0.69% |
| 2005 Q1 | 406.12 Million CNY | 16.93% |
| 2005 FY | 1.55 Billion CNY | 11.25% |
| 2004 Q3 | 330.49 Million CNY | -6.28% |
| 2004 Q1 | 365.77 Million CNY | 5.62% |
| 2004 FY | 1.39 Billion CNY | -0.02% |
| 2004 Q4 | 347.32 Million CNY | 5.09% |
| 2004 Q2 | 352.64 Million CNY | -3.59% |
| 2003 Q1 | 377.33 Million CNY | 20.96% |
| 2003 Q2 | 339.3 Million CNY | -10.08% |
| 2003 Q3 | 333.61 Million CNY | -1.68% |
| 2003 FY | 1.39 Billion CNY | 6.33% |
| 2003 Q4 | 346.32 Million CNY | 3.81% |
| 2002 Q1 | 337.6 Million CNY | 0.0% |
| 2002 Q4 | 311.95 Million CNY | -1.73% |
| 2002 Q3 | 317.46 Million CNY | -8.34% |
| 2002 Q2 | 346.36 Million CNY | 2.6% |
| 2002 FY | 1.31 Billion CNY | 12.24% |
| 2001 FY | 1.17 Billion CNY | 14.55% |
| 2000 FY | 1.02 Billion CNY | 17.54% |
| 1999 FY | 869.1 Million CNY | 7.07% |
| 1998 FY | 811.73 Million CNY | 4.56% |
| 1997 FY | 776.34 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 167.43 Million HKD | -8373.264% |
| Grand Pharmaceutical Group Limited | 6.52 Billion HKD | -117.461% |
| Extrawell Pharmaceutical Holdings Limited | 28.77 Million HKD | -49197.385% |
| Wai Yuen Tong Medicine Holdings Limited | 394.81 Million HKD | -3493.421% |
| Qianhai Health Holdings Limited | -35.6 Million HKD | 39948.592% |
| Lee's Pharmaceutical Holdings Limited | 551.31 Million HKD | -2473.374% |
| Essex Bio-Technology Limited | 1.53 Billion HKD | -821.676% |
| Tongfang Kontafarma Holdings Limited | 471.29 Million HKD | -2910.298% |
| PuraPharm Corporation Limited | 216.62 Million HKD | -6449.121% |
| SSY Group Limited | 3.48 Billion HKD | -306.608% |
| JBM (Healthcare) Limited | 319.41 Million HKD | -4341.635% |
| Jacobson Pharma Corporation Limited | 620.47 Million HKD | -2186.522% |
| China Resources Pharmaceutical Group Limited | 43.36 Billion HKD | 67.285% |